Logo.png
Foresight Leverages NVIDIA Jetson Orin to Introduce Novel 360-degree 3D Perception Solution
May 08, 2024 08:06 ET | Foresight Autonomous Holdings Ltd.
NVIDIA Jetson AGX Orin system-on-module is used to accelerate autonomous agriculture and heavy machinery projects Ness Ziona, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Foresight Autonomous...
Applied Digital - Logo - Horizontal - Black.png
Applied Digital Announces Upcoming Conference Participation
May 08, 2024 08:05 ET | Applied Digital Corporation
DALLAS, May 08, 2024 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure...
nano-logo (002).jpg
USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
May 08, 2024 08:00 ET | Nano-X Imaging LTD.
Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an...
FMC Logo with trademark.jpg
First Merchants Corporation Announces Cash Dividend
May 08, 2024 08:00 ET | First Merchants Corporation
MUNCIE, Ind., May 08, 2024 (GLOBE NEWSWIRE) -- First Merchants Corporation declared a cash dividend on May 7, 2024 of $0.35 per share. The dividend is payable on June 21, 2024, to shareholders of...
LSTA Logo Final 6.8.22_Logo Color_Transparant Background (002).jpg
Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
May 08, 2024 08:00 ET | Lisata Therapeutics, Inc.
BASKING RIDGE, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies...
BCAB.jpg
BioAtla to Participate in the Citizens JMP Life Sciences Conference
May 08, 2024 08:00 ET | BioAtla, Inc.
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody...
SRAX Signs Agreement to Merge with DNA Holdings
May 08, 2024 08:00 ET | SRAX, Inc.
Westlake Village, CA, May 08, 2024 (GLOBE NEWSWIRE) -- SRAX Inc. (OTC: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform...
Spero logo.jpg
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
May 08, 2024 08:00 ET | Spero Therapeutics, Inc.
CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel...
Monster Beverage Corporation Logo
Monster Beverage Corporation Commences Modified Dutch Auction Tender Offer to Purchase Up to $3.0 Billion of Its Outstanding Common Stock
May 08, 2024 08:00 ET | Monster Beverage Corporation
CORONA, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ: MNST) today announced that it has commenced a modified “Dutch auction” tender offer to purchase shares of its...
Cue Logo Horizontal.jpg
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
May 08, 2024 08:00 ET | Cue Biopharma, Inc.
BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...